872606-49-0

872606-49-0 structure

Name: Levofloxacin sodium
Chemical Name: Levofloxacin sodium
CAS Number: 872606-49-0
Molecular Formula: C₁₈H₁₉FN₃NaO₄
Molecular Weight: 383.34900
Catalog: Signaling Pathways Anti-infection Bacterial
Create Date: 2017-05-20 11:19:26
Modify Date: 2025-08-25 16:45:17
Levofloxacin ((-)-Ofloxacin) sodium is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin sodium inhibits the DNA gyrase and topoisomerase IV. Levofloxacin sodium can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin sodium shows anti-orthopoxvirus activity[1][2][3][4][5].

Name	Levofloxacin sodium
Synonyms	unii-1nf639gzuu

Description	Levofloxacin ((-)-Ofloxacin) sodium is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin sodium inhibits the DNA gyrase and topoisomerase IV. Levofloxacin sodium can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin sodium shows anti-orthopoxvirus activity[1][2][3][4][5].
Related Catalog	Signaling Pathways >> Cell Cycle/DNA Damage >> Topoisomerase Research Areas >> Infection Signaling Pathways >> Cell Cycle/DNA Damage >> DNA/RNA Synthesis Research Areas >> Inflammation/Immunology Signaling Pathways >> Anti-infection >> Bacterial
References	[1]. Smee DF, et al. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res. 2003 Jan;57(1-2):41-52. [2]. Siva, R., et al., Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis, 2014. 9: p. 179-86. [3]. Pradeep, A.R., et al., Clinical and microbiological effects of levofloxacin in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. J Investig Clin Dent, 2014. [4]. Lee, B.T., et al., Efficacy of Levofloxacin in the Treatment of BK Viremia: A Multicenter, Double-Blinded, Randomized, Placebo-Controlled Trial. Clin J Am Soc Nephrol, 2014. [5]. Drlica K, et al. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92.

Molecular Formula	C₁₈H₁₉FN₃NaO₄
Molecular Weight	383.34900
Exact Mass	383.12600
PSA	77.84000
LogP	0.21220

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

872606-49-0	2206135-16-0
160962-46-9	1607796-83-7
2699607-50-4	226578-51-4
1261398-33-7	1797510-34-9
30605-57-3	54600-91-8
2229015-64-7	2110531-22-9
2227779-39-5	2172503-37-4
2172072-50-1	2228145-01-3
2229380-46-3	2229200-05-7
2228943-35-7	2649080-78-2